StockVS

NASDAQ · USD

Klotho Neurosciences, Inc. (KLTOW) Stock Analysis

Klotho Neurosciences, Inc. (KLTOW) is a stock listed on NASDAQ and quoted in US Dollar.

KLTOW

$0.09

−$0.01 (−13.13%)

Last trade March 11, 2026

This is a derivative instrument — a warrant on Klotho Neurosciences Inc (KLTO) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View KLTO →

Price History

Hover for the daily close. The dotted line marks the period open.

KLTOW Key Statistics

As of Mar 11, 2026
Trading
Open
$0.17
Previous Close
$0.10
Day's Range
0.08–0.10
52-Week Range
0.08–0.10
Volume
18.57K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.23

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

KLTOW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−25.41%
2025 (partial year)+0.00%

As of March 11, 2026.

About Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.

Visit website →